FeaturedNeurologyNeuroscience·January 19, 2022·5 min readCholesterol Buildup in Brain Presents New Target to Reduce Dementia Risk From StrokeCyclodextrin, an FDA-approved drug, reduced cholesterol accumulation from broken down brain cells and inflammation in animal models. The findings point to a potential new therapy to reduce dementia following a stroke.Read More
